Bright Minds Biosciences DRUG
NASDAQ DRUG
$23.45 +0.84 (+3.72%)
At close: Nov 11, 2026 · 4:00 PM EST

Bright Minds Biosciences (DRUG) Accounts Payables (2020 - 2026)

Updated

Bright Minds Biosciences (DRUG) posted Accounts Payables of $1.79 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 371.2% from $380,200 a year earlier but down 34.5% from the prior quarter.

Analysis

Bright Minds Biosciences (DRUG) Accounts Payables (2020 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Bright Minds Biosciences' Accounts Payables came in at $1.61 million, up 387.5% from FY2024.

  • Annual Accounts Payables shows a five-year compound annual growth rate of 70.3% (FY2020 to FY2025).
  • In prior fiscal years, Bright Minds Biosciences' Accounts Payables was $330,326 in FY2024 (+114.8%), $153,757 in FY2023 (-86.0%), $1.1 million in FY2022 (+117.8%) and $505,261 in FY2021 (+350.0%).
  • Quarterly Accounts Payables has run from a low of $120,355 in fiscal Q3 2024 to a high of $2.73 million in fiscal Q2 2026 over five years.
  • On a year-over-year basis, Accounts Payables has increased in each of the last five quarters, with growth averaging 236.8% over the last eight quarters.
  • The strongest year-over-year quarter for Accounts Payables in the past five years was fiscal Q2 2026, with growth of 600.5%; the weakest was fiscal Q4 2023, with a decline of 85.6%.
  • According to Business Quant data, Accounts Payables for the three prior fiscal quarters was $2.73 million (Q2 2026), $1.07 million (Q1 2026) and $1.64 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 5.79 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 9.32 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 34.43 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.03 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -23.57 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 2.95 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 934.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.07 Bn
10 Bright Minds Biosciences 172.65 Mn -390.95 Mn - 1.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.74 Mn
Mar 31, 2026 2.69 Mn
Dec 31, 2025 1.09 Mn
Sep 30, 2025 1.62 Mn
Jun 30, 2025 385,050.51
Mar 31, 2025 391,510.31
Dec 31, 2024 270,984.25
Sep 30, 2024 332,597.28
Jun 30, 2024 120,160.89
Mar 31, 2024 599,183.64
Dec 31, 2023 604,399.95
Sep 30, 2023 153,663.18
Jun 30, 2023 485,587.89
Mar 31, 2023 689,399.43
Dec 31, 2022 338,091.77
Sep 30, 2022 1.03 Mn
Jun 30, 2022 299,087.98
Mar 31, 2022 803,950.39
Dec 31, 2021 384,165.57
Sep 30, 2021 500,692.34
API Access

Bright Minds Biosciences Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=DRUG&period=max&api_key=YOUR_API_KEY